PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The Wistar Institute, Philadelphia, PA, United States.\', \'The Burnet Institute, Melbourne, VIC, Australia.\', \'Department of Infectious Diseases, Monash University, Melbourne, VIC, Australia.\', \'Rush Center for Integrated Microbiome and Chronobiology Research, Rush University, Chicago, IL, United States.\', \'Department of Internal Medicine, Rush University Medical Center, Chicago, IL, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.686240
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34177935
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34177935>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34177935>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all